June 13, 2025

Industry Overview Europe’s active pharmaceutical ingredients (API) market was valued at $45.4 billion in 2024 and is projected to grow at a CAGR of 5.9% during the forecast period (2025-2035). The European API industry is among the most powerful and basic components of the global pharma ecosystem. As the fundamental ingredient of each pharma drug, […]

Imatinib Mesylate Market is driven by growing adoption of generic imatinib formulations across developing economies, improving drug accessibility and affordability. Industry Overview Imatinib mesylate market Imatinib mesylate, also known as a Tyrosine Kinase Inhibitor (TKI), is mainly indicated for the treatment of Chronic Myeloid Leukemia (CML), Acute Lymphoblastic Leukemia (ALL), and Gastrointestinal Stromal Tumors (GIST).